Edition:
United States

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

1.79USD
12 Dec 2017
Change (% chg)

$-0.04 (-2.19%)
Prev Close
$1.83
Open
$1.84
Day's High
$1.84
Day's Low
$1.74
Volume
41,821
Avg. Vol
86,963
52-wk High
$13.24
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​
Monday, 18 Sep 2017 08:00am EDT 

Sept 18 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics Inc - ‍HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.60
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports second quarter 2017 results.Q2 loss per share $0.60.Q2 revenue $1.8 million.Sees FY 2017 revenue $9.0 million to $12 million.  Full Article

HTG Molecular Diagnostics initiates second development program under co's master agreement with unit of Qiagen N.V.
Thursday, 27 Jul 2017 09:00am EDT 

July 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics - initiation of second development program under co's master agreement with unit of Qiagen N.V..  Full Article

Novo Holdings reports 12.03 pct stake in HTG Molecular Diagnostics as on July 3
Thursday, 20 Jul 2017 06:22am EDT 

July 20 (Reuters) - Htg Molecular Diagnostics Inc -:Novo Holdings A/S reports 12.03 percent stake in HTG Molecular Diagnostics Inc as on July 3, 2017 - sec filing‍​.Novo Holdings A/S had previously reported 15.9 percent stake in HTG Molecular Diagnostics Inc as on March 23, 2017 - sec filing‍​.  Full Article

HTG Molecular Diagnostics has launched new HTG EdgeSeq PATH Assay
Wednesday, 28 Jun 2017 04:01pm EDT 

June 28 (Reuters) - HTG Molecular Diagnostics Inc ::Has launched its new HTG EdgeSeq path assay for sale in U.S. and Europe.  Full Article

HTG Molecular Diagnostics Inc enters statement of work with subsidiary of QIAGEN N.V
Wednesday, 14 Jun 2017 05:45pm EDT 

June 14 (Reuters) - HTG Molecular Diagnostics Inc : :HTG Molecular Diagnostics Inc - effective June 14, co entered statement of work with subsidiary of Qiagen N.V.HTG Molecular- co, Qiagen expected to do development work for initial phase of project leading to development of sequencing-based companion diagnostic assay.HTG Molecular Diagnostics Inc - Qiagen will pay co low single digit millions of dollars for initial phase development work performed under sow.HTG Molecular Diagnostics Inc - co and Qiagen will also share in any net profits generated by initial phase.  Full Article

HTG Molecular amends, restates IVD test development, component supply agreement with Illumina
Monday, 5 Jun 2017 08:00am EDT 

June 5 (Reuters) - HTG Molecular Diagnostics Inc ::Amended and restated its IVD test development and component supply agreement with Illumina.HTG Molecular Diagnostics - agreement extends term, increases number of in-vitro diagnostic test kits that may be developed with Illumina sequencing technology.  Full Article

HTG Molecular Diagnostics says ‍entered amended and restated development and component supply agreement with illumina
Friday, 2 Jun 2017 06:03pm EDT 

June 2 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics - ‍entered amended and restated development and component supply agreement with illumina, inc effective may 31 - sec filing​.HTG Molecular Diagnostics - ‍co required to pay illumina up to $0.6 million upon achievement of specified regulatory milestones relating to ivd test kits​.HTG Molecular Diagnostics- agreed to pay illumina single digit percent royalty on net sales of ivd test kits co commercializes pursuant to restated deal ‍​.HTG Molecular-‍filed amendment to prospectus supplement to increase amount of stock that may be offered in atm offering under sales deal to $40 million.  Full Article

HTG Molecular Q1 loss per share $0.73
Monday, 15 May 2017 04:01pm EDT 

May 15 (Reuters) - Htg Molecular Diagnostics Inc ::HTG Molecular Diagnostics reports first quarter 2017 results.Q1 loss per share $0.73.Q1 revenue rose 58 percent to $1.4 million.  Full Article